| Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study |
Yunpeng Yu |
Indiana University |
PLCO |
Nov 1, 2022 |
PLCO-1088 |
| Deep learning for indirect and direct cardiovascular risk estimation from ungated chest CT |
Piotr Slomka |
Cedars-Sinai |
NLST |
Nov 1, 2022 |
NLST-981 |
| ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING |
Kezban Alpan |
Middlesex University |
PLCO |
Nov 1, 2022 |
PLCO-1089 |
| Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials |
Alison Rustagi |
University of California, San Francisco |
LSS |
Oct 27, 2022 |
LSS-3 |
| Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis |
Ben Armstrong |
Massachusetts Institute of Technology |
PLCO |
Oct 27, 2022 |
PLCO-1080 |
| Development of CAD for lung nodule screening |
Naïm Jalal |
GE HEALTHCARE |
NLST |
Oct 27, 2022 |
NLST-977 |
| Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
| Synthetic generation and tagging of CXR and pathology images |
Jonathan Pearson |
NHS Commissioning Board (NHS England) |
PLCO |
Oct 18, 2022 |
PLCOI-1077 |
| Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics |
Graham Chapman |
Case Western Reserve University |
PLCO |
Oct 18, 2022 |
PLCO-1074 |
| Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) |
Mary Playdon |
University of Utah |
PLCO |
Oct 18, 2022 |
PLCO-1067 |
| Impact of Data Driven Decision Making in Healthcare Analytic |
May Myat |
University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar |
PLCO |
Oct 18, 2022 |
PLCO-1064 |
| Mathematical modelling of prostate cancer data |
Taylor deVet |
McMaster University |
PLCO |
Oct 18, 2022 |
PLCO-1073 |
| Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials |
Alison Rustagi |
University of California, San Francisco |
NLST |
Oct 18, 2022 |
NLST-972 |
| Machine Learning Analysis for Lung Cancer Progression |
Anderson Nnewihe |
Johnson & Johnson Enterprise Innovation, Inc. |
NLST |
Oct 18, 2022 |
NLST-973 |
| Looking for the retrospective link between cigarette habits in men and prostate cancer |
Tamara yaghi |
American international School of riyadh |
PLCO |
Oct 11, 2022 |
PLCO-1071 |
| PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
| Comparative analysis of the cost-effectiveness and implementation of lung cancer screening with LDCT in the US and EU |
Tanya Rajabi |
Semmelweis University |
NLST |
Oct 11, 2022 |
NLST-968 |
| Lung cancer risk assessment |
Adam Vasserstrom |
Nucleix |
NLST |
Oct 11, 2022 |
NLST-965 |
| Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
Sigrid Carlsson |
Memorial Sloan Kettering Cancer Center |
PLCO |
Oct 6, 2022 |
2021-1016 |
| Dissecting the risk of MGUS/MM in high-risk participants in the PLCO study |
Irene Ghobrial |
Dana-Farber Cancer Institute |
PLCO |
Oct 6, 2022 |
2021-1015 |
